1. Home
  2. RGS vs TIL Comparison

RGS vs TIL Comparison

Compare RGS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

N/A

Current Price

$23.13

Market Cap

66.3M

ML Signal

N/A

Logo Instil Bio Inc.

TIL

Instil Bio Inc.

HOLD

Current Price

$8.91

Market Cap

74.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGS
TIL
Founded
1922
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.3M
74.7M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
RGS
TIL
Price
$23.13
$8.91
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$125.00
AVG Volume (30 Days)
8.9K
61.4K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
20.24
52.54
EPS
0.64
N/A
Revenue
$210,134,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$36.13
N/A
Revenue Growth
3.52
N/A
52 Week Low
$15.00
$5.67
52 Week High
$31.50
$42.75

Technical Indicators

Market Signals
Indicator
RGS
TIL
Relative Strength Index (RSI) 45.25 56.40
Support Level $18.63 $6.85
Resistance Level $23.65 $9.81
Average True Range (ATR) 0.68 0.58
MACD 0.21 0.16
Stochastic Oscillator 70.73 60.26

Price Performance

Historical Comparison
RGS
TIL

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: